Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Avanir Pharmaceuticals' Revenue Soars 62% on Strong Nuedexta Sales
Avanir Pharmaceuticals' Revenue Soars 62% on Strong Nuedexta Sales
Avanir Pharmaceuticals' Revenue Soars 62% on Strong Nuedexta Sales
Submitted by
admin
on February 5, 2014 - 6:56pm
Source:
Motley Fool
News Tags:
earnings
Avanir
Headline:
Avanir Pharmaceuticals' Revenue Soars 62% on Strong Nuedexta Sales
Do Not Allow Advertisers to Use My Personal information
